BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22469947)

  • 1. Skin involvement in a newborn with down syndrome and transient myeloproliferative disorder.
    Natesirinilkul R; Charoenkwan P; Tantiprabha W; Pruksachartkun C; Ya-In C
    J Pediatr Hematol Oncol; 2012 May; 34(4):e171-2. PubMed ID: 22469947
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of dysplastic platelets by peripheral blood megakaryoblasts in transient myeloproliferative disorder in Down syndrome.
    Chopra A; Kumar R; Kabra M; Anand M
    Platelets; 2008 Mar; 19(2):160-1. PubMed ID: 18297553
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
    Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal vesiculopustular eruption associated with transient myeloproliferative disorder: report of four cases.
    Narvaez-Rosales V; de-Ocariz MS; Carrasco-Daza D; Ramirez-Davila B; Orozco-Covarrubias L; Duran-McKinster C; Palacios-Lopez C
    Int J Dermatol; 2013 Oct; 52(10):1202-9. PubMed ID: 23046498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
    Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
    Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin involvement in Down syndrome transient abnormal myelopoiesis.
    Krawczyk J; McDermott M; Irvine AD; O'Marcaigh A; Storey L; Smith O
    Br J Haematol; 2012 May; 157(3):280. PubMed ID: 22385123
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient megakaryoblastic proliferation in a newborn infant with Down's syndrome.
    Hayashi Y; Hanada R; Yamamoto K; Ohde S; Niitsu N; Eguchi M; Sugita K; Nakazawa S
    Cancer Genet Cytogenet; 1987 Oct; 28(2):373-4. PubMed ID: 2957044
    [No Abstract]   [Full Text] [Related]  

  • 8. Diffuse hepatic fibrosis with transient myeloproliferative disorders in Down syndrome.
    Hongeng S; Pakakasama S; Hathirat P; Phuapradid P; Worapongpaiboon S
    J Pediatr Hematol Oncol; 2000; 22(6):543-4. PubMed ID: 11132225
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient abnormal myelopoiesis complicated by tumor lysis syndrome.
    Abe Y; Mizuno K; Horie H; Mizutani K; Okimoto Y
    Pediatr Int; 2006 Oct; 48(5):489-92. PubMed ID: 16970788
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myeloproliferative disorder associated with Down's syndrome].
    Zolezzi P; Calle H; Norambuena L; Mena MA
    Rev Chil Pediatr; 1980; 51(6):448-9. PubMed ID: 6452659
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient myeloproliferative disorder in Down's syndrome.
    Kshirsagar VY; Ahmed M; Colaco SM; Ahmed M
    Indian J Pathol Microbiol; 2012; 55(3):426-7. PubMed ID: 23032858
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient myeloproliferative disorder and eosinophilic pericardial effusion in a down syndrome neonate.
    Shenoy RD; Bhat KG; Kamath N; Kumble Y
    Pediatr Hematol Oncol; 2008 Mar; 25(2):123-9. PubMed ID: 18363179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down syndrome and the myeloproliferative disorder.
    Amendola G; Amato L; Cirillo G; Dante G
    Clin Pediatr (Phila); 1990 Aug; 29(8):486. PubMed ID: 2145112
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathologic quiz case: nonimmune hydrops in a newborn. Down syndrome with acute (transient) leukemia.
    Oetama BK; Tucay RF; Morgan DL
    Arch Pathol Lab Med; 2001 Dec; 125(12):1609-10. PubMed ID: 11735703
    [No Abstract]   [Full Text] [Related]  

  • 15. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
    Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
    Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine diagnosis and management of transient myeloproliferative disorder.
    Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
    Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis.
    Schwab M; Niemeyer C; Schwarzer U
    Med Pediatr Oncol; 1998 Sep; 31(3):159-65. PubMed ID: 9722898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders.
    Piersigilli F; Diociaiuti A; Boldrini R; Auriti C; Curci M; El Hachem M; Seganti G
    Cutis; 2010 Jun; 85(6):286-8. PubMed ID: 20666188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital GATA1-mutated myeloproliferative disorder in trisomy 21 complicated by placental fetal thrombotic vasculopathy.
    Loh TJ; Lian DW; Iyer P; Lam JC; Kuick CH; Aung AC; Chang KT
    Hum Pathol; 2014 Nov; 45(11):2364-7. PubMed ID: 25248574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
    Zipursky A; Brown EJ; Christensen H; Doyle J
    Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.